Skip to main content
OpenTrials
Completed

NCT Number: NCT07180810

Effect of Dexmedetomidine Infusion on Post Anesthesia Discharge Time

A randomised control trial evaluating the effect of low dose dexmedetomidine infusion on post anesthesia discharge time in patients of day case breast cancer surgery compared with placebo infusion. The primary outcome was to compare the frequency of early discharge in each group.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Shaukat Khanum Memorial Cancer Hospital and Research Centre

Lahore, Pubjab, 54782, Pakistan

About this study

A prospective Randomised control trial evaluating the effect of low dose dexmedetomidine infusion on post anesthesia discharge time in patients of day case breast cancer surgery compared with placebo infusion. The primary outcome was to compare the frequency of early discharge in each group. Early discharge was defined as within two hours. The sample size was of 82 female patients with a specific inclusion and exclusion criteria. Randomisation was done through computer software and the trial was double blinded. SPSS version 22 will be used for data analysis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18-60 yrs, ASA 1 and 2, elective breast cancer surgery

Exclusion criteria

  • BMI greater than 35, CKD stage 3 or greater, known drug allergy to study drug, bradycardia, history of PONV, patients on antiepileptics

Treatment and study plan

Dexmedetomidine infusion low dose

Drug

low dose dexmedetomidine infusion at rate 0.6mcg/kg/hour rate .

Group B receiving normal saline

Drug

Normal saline infusion at rate 0.6mcg/kr/hour rate

Primary outcomes

  1. Frequency of early discharge

    Time frame: 120 minutes

    post anesthesia discharge time within 2 hours

Sponsors and collaborators

Lead sponsor

Shaukat Khanum Memorial Cancer Hospital & Research Centre

Other

Registry information

Official study title

Effect of Low Dose Intravenous Dexmedetomidine on Post Anesthesia Discharge After Day Case Breast Cancer Surgery

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Sep 18, 2025
Registry last updated
Sep 23, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.